Ulrich Naher - Mar 8, 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
EVP, Chief Commercial Officer
Signature
Jonathan B. Leiken, Attorney in fact for Ulrich Naeher
Stock symbol
DBD
Transactions as of
Mar 8, 2022
Transactions value $
$0
Form type
4
Date filed
3/10/2022, 03:29 PM
Previous filing
Feb 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Shares Award $0 +168K +83.97% $0.00 369K Mar 8, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding DBD Non-Qualified Stock Options 49.7K Mar 8, 2022 Common Shares 49.7K $26.60 Direct F3
holding DBD Non-Qualified Stock Option 30.3K Mar 8, 2022 Common Shares 30.3K $18.75 Direct F4
holding DBD Non-Qualified Stock Option 47.4K Mar 8, 2022 Common Shares 47.4K $4.08 Direct F4
holding DBD Non-Qualified Stock Option 12.6K Mar 8, 2022 Common Shares 12.6K $11.96 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of restricted stock units; each restricted stock unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
F2 Number includes restricted stock units.
F3 Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F4 Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.